Latest Stock Buy or Sell? Make More Informed Decisions!
Today, Kim Bolton and Stockchase Insights commented about whether VRT-N, NCI-X, FTS-T, HYMTF-OTC, DASTY-OTC, TER-N, IBM-N, MDB-Q, MSFT-Q, NVDA-Q, KEYS-N, ARM-Q, META-Q, TEAM-Q, LRCX-Q, ORCL-N, AVGO-Q, MU-Q, WDC-Q, ASML-Q, UBER-N, GOOG-Q, AMZN-Q, AAPL-Q, TSLA-Q, CTS-T, DND-T are stocks to buy or sell.
- Page 2/3
- Next Page
Reports next week. He has a pretty full position at about 7%. He'd even start a position here around $571, and add around the lower $550 range, and $525. Very good support around $520. His 12-month price target is $645. Thinks it has the biggest database of all the players out there. That's why it buys about $38-39B worth of NVDA chips, to process all that data.
Its natural processing language model, Llama, will sell the processing of its (and others') data to software companies such as NOW and CRM. That's how it's going to monetize all that data. Thinks this stage will happen in 2025.
Last time it reported, actually got all the way down to $95 a couple of days later. One of his largest positions. 12-month price target of $149.85. If it got above $143, he'd probably write some calls. The new Blackwell chip is completely sold out all through 2025, and no one else has come out with a better widget.
It's the darling of the tech arena right now. Don't go all in. Buy here around $139, and try for $125, $115, and $105. A gift if you could ever get it under $100. If it went under $90, get out of the way.
The dilemma that professional money managers go through every day! If you sell a small portion of a winner, you win whether the stock goes up or down. If you sell 15% of your stake, and it continues to go up, you still have a lot. But if it goes down, you can pat yourself on the back for being so smart (and now you can buy it back).
One of his top 5. His 12-month price target is $491, so still about 20% upside. Has been dead money over the last couple of months, as the rest of the market's taken off. So many horses in the race, from software to hardware to cloud to cross-selling. Its Maia AI chip is very competitive. If it got north of $450, that's where he'd take 10-15% off.
Makes equipment for the chip industry. Recall the dartboard chart described at the top of today's show of the automation/robotics ecosystem. In the hardware space, just outside the manufacturers. Testing equipment for semiconductors, wireless, storage devices. Ensures quality and reliability of high-tech products. About 20% runway to $150. Yield is 0.4%.
What's also very cool is that, yes, it's in automation. But it's also gotten into robotics to the tune of about 25% CAGR growth rate consistently for the last 2 years, compared to 20% for peers. Definitely a leader, great company.
Known as an airline company, but they have this software to fiddle with manufacturing systems on your computer screen. As a result, big player in robotics. More on the outer circle of the dartboard graph of the robotics ecosystem. 12-month price target of $41.50 Get a position here ~$35.50, and add in the lower $30s. Yield is 0.7%.
(Analysts’ price target is $44.00)One of the bigger players on the manufacturing side. Big automotive business in affordable passenger vehicles, but also big on the EV side. Back in 2020, it bought Boston Dynamics, a leader in leveraging robotics for industrial automation and mobility.
A bit difficult to buy -- has an ADR on the NASDAQ, but can also buy it on the Korea Exchange (KRX).
It is true that lower rates should otherwise be a tailwind for businesses with leveraged balance sheets. In fact, FTS has recovered meaningfully to reach 52-week highs recently. We think for a conservative name like FTS its performance is quite good. The upside potential from the interest rate tailwinds may not be as attractive as it used to be, but we think FTS is still a high-quality dividend payer. We think FTS can do well from here for shareholders with a potential total return of around 10% annualized return over the long-term.
Unlock Premium - Try 5i Free
NCI just issued an equity offering at a price of $1.4 for aggregate proceeds of $5.2M. The size of the offering is quite large (10% of NCI's market cap) relative to previous years’ equity issuance of around $1M. The purpose of the issuance could be to fund growth and take advantage of the record valuation in its share price.
NCI just recently raised guidance for FY2024. NCI expects revenue to be around $55M, an increase of 10% over the previous projection of $50M, along with a revised net income margin to 14% from 10% previously. The result is driven by a sustained and rising demand from new and existing customers.
Overall, NCI is demonstrating strong execution, NCI is an interesting, profitable growth story that has shown solid momentum. But its market cap is just $50M, a really small and illiquid stock. We would be comfortable to add to NCI over time as the company continues to execute and we would be willing to average up.
Unlock Premium - Try 5i Free
The quarter was solid, and ahead of estimates. Guidance was also raised, though not by a huge amount. After some 'selling on news' and profit taking, shares reversed up and hit another new high before the weak Nasdaq market brought them down again. But the performance and outlook remain solid and we would be fine buying some today or in any further decline.
Unlock Premium - Try 5i Free
(Note 10 for 1 stock split October 3, 2024)
(Analysts’ price target is $92.75)Got caught in the backwash of ASML. Reports tonight. He's on board with the analysts' average price target, getting close to being fully priced. Watch tonight when earnings come out, and listen for comparisons with ASML. Good support on the chart around $71. Next support after that is around $57. A great place to buy would be in low-mid $60s.